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Abstract
Background: The aim of the present study was to determine the 
prevalence of thyroid dysfunction in patients with type 2 diabetes 
(T2D) attending an outpatient clinic.
Methods:  We examined thyroid dysfunction in a total of 1,092 
patients with T2D.
Results:  Prevalence rate of thyroid dysfunction was 12.3%. In the 
group with thyroid dysfunction there was an excess of females in 
comparison with the group without thyroid dysfunction (P < 0.001). 
In addition, patients with thyroid dysfunction had higher values of 
body mass index (P = 0.03) and HDL-cholesterol levels (P = 0.01), 
and lower values of LDL-cholesterol levels (P = 0.001) in compari-
son with patients without thyroid dysfunction. Multivariate analysis 
demonstrated that presence of thyroid dysfunction was related with 
gender (OR: 0.220, 95% CI: 0.141 - 0.352) and LDL-cholesterol 
levels (OR: 0.990, 95% CI: 0.985 - 0.995).
Conclusions:  The prevalence of thyroid dysfunction among Greek 
diabetic patients is 12.3%. Diabetic women were more frequently 
affected than men. Presence of thyroid dysfunction was associated 
with lower levels of LDL-cholesterol concentrations.
Keywords:  Type 2 diabetes mellitus; Thyroid dysfunction; Hypo-
thyroidism; Gender; LDL-cholesterol; Greece
Introduction
The first reports showing the association between diabetes 
and thyroid dysfunction were published in 1979 [1, 2]. Since 
then a lot of studies in different countries have tried to esti-
mate the prevalence of thyroid dysfunction among diabetic 
patients [1-5]. The reported prevalence of thyroid dysfunc-
tion in diabetes varying from 2.2 to 17% [1-4]. Another study 
reported high prevalence of abnormal TSH concentration in 
patients with type 2 diabetes (T2D) (31%) [5]. In addition, 
diabetic women are more frequently affected than men and 
hypothyroidism is more common than thyrotoxicosis [5]. It 
has been showed that subclinical hypothyroidism affects al-
most one in 20 women with T2D [5].
To the best of our knowledge no studies have been done 
to estimate the prevalence of thyroid dysfunction in type 2 
diabetic patients in our country. Therefore, the aim of the 
present study was to determine the prevalence of thyroid 
dysfunction  in  patients  with T2D  attending  an  outpatient 
clinic.
 
Patients and Methods
Subjects
We examined a total of 1,092 patients with T2D attending 
the diabetes outpatient clinic of our hospital from January 
2008 to June 2009. Diagnosis of diabetes was based on the 
American Diabetes Association criteria [6]. Patients with at 
least three visits the last year were enrolled in the study. A 
medical history, regarding the age at diagnosis of diabetes, 
the presence of cardiovascular disease, the presence of dia-
betic complications, and current medication, was obtained. 
Patients who reported taking T4, T3, carbimazole, methima-
zole or propylthiouracil, and those with a history of thyroid-
ectomy, radioactive iodine treatment, were identified as hav-
ing thyroid dysfunction.
The study protocol was approved by the Scientific and 
Ethical Committee of the General Hospital of Nikaia. Full 
informed written consent was obtained from all patients. 
Methods
Blood samples were drawn after 10-12 hours fast, for mea-
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surement of plasma HbA1c and lipid profile. Body weight 
with subjects in light clothing without shoes and height was 
measured and body mass index (BMI) was calculated. Blood 
pressure was recorded as the mean of three consecutive mea-
surements in the sitting position taken 5 min apart. Hyper-
tension was defined according to the current guidelines [7] 
as BP levels ≥ 140/90 mm Hg or the use of anti-hypertensive 
drugs. 
Coronary artery disease (CAD) was defined as presence 
of angina,  history of previous myocardial infarction, posi-
tive stress testing, revascularization procedures or stenosis > 
50% at the coronary arteries. The renal status was based on 
the albumin excretion rate (AER) measured in at least two 
out of three consecutive 24-h timed urine collections. Pa-
tients were classified as normo- (AER < 20 mg/min), micro- 
(AER 20 - 199 mg/min), or macroalbuminurics (AER>200 
mg/min). Direct fundoscopy was performed in all patients 
through dilated pupils.
Statistical analysis   
Statistical  analysis  was  preformed  using  programs  avail-
able in the SPSS statistical package (SPSS 15.0, Chicago, 
USA). All variables were tested for normal distribution of 
the data. Data are shown as mean ± SD, unless it is stated 
otherwise. A two sample t-test was used to assess differences 
in continuous variables, while a chi-square test was used for 
categorical variables. Univariate binary logistic analysis was 
performed to look for the relationship between thyroid dys-
function and the variables of interest in the sample popula-
tion. Then, multivariate analysis was performed (backward 
stepwise method) to look for independent associations be-
tween thyroid dysfunction and the variables of interest. All 
independent variables in the multivariate analysis were test-
ed for multicolinearity. P < 0.05 was considered statistically 
significant.
 
Results
Prevalence  rate  of  thyroid  dysfunction  was  12.3%  in  the 
study group. The clinical and laboratory characteristics of 
the study patients according to the presence or absence of 
thyroid dysfunction are showed in Table 1. 
Diabetic subjects with 
thyroid dysfunction
Diabetic subjects without 
thyroid dysfunction
P
N 134 958
Age (yrs) 65.53 ± 11.77 67.07 ± 12.11 0.17
Males/females n (%) 29 (21.6)/105 (78.4) 495 (51.7)/463 (48.3) < 0.001
Body mass index (Kg/m2) 31.76 ± 5.67 30.65 ± 5.47 0.03
Duration of diabetes (yrs) 14.28 ± 9.55 14.64 ± 9.66 0.68
Systolic blood pressure (mm Hg) 137.46 ± 18.42 134.73 ± 18.20 0.11
Diastolic blood pressure (mm Hg) 77.87 ± 10.41 78.63 ± 10.05 0.41
HbA1c (%) 7.38 ± 1.57 7.81 ± 1.69 0.18
Total cholesterol (mg/dl) 199.80 ± 98.30 207.24 ± 57.31 0.15
HDL cholesterol (mg/dl) 51.70 ± 20.45 47.35 ± 18.91 0.01
LDL cholesterol (mg/dl) 114.94 ± 41.48 128.05 ± 42.87 0.001
Triglycerides (mg/dl) 161.41 ±119.72 164.39 ± 103.54 0.76
Hypertension (yes) n (%) 85 (63.4) 553 (57.7) 0.21
Dyslipidemia (yes) n (%) 70 (52.2) 439 (45.8) 0.16
Retinopathy (yes) n (%) 27 (20.1) 171 (17.9) 0.52
Nephropathy (yes) n (%) - 39 (4.1) -
Coronary artery disease (yes) n (%) 23 (17.2) 165 (17.3) 0.98
Treatment for diabetes n (%)
Antidiabetic tablets 85 (63.4) 628 (65.6) 0.63
Insulin 47 (35.1) 323 (33.7) 0.75
Table 1. Clinical and Laboratory Characteristics of Diabetic Patients According to the Presence of Thyroid Dysfunction
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Diabetic  patients  with  and  without  thyroid  dysfunc-
tion did not differ in terms of age and duration of diabetes. 
However, in the group of diabetic patients with thyroid dys-
function there was an excess of females in comparison with 
the group without thyroid dysfunction (78.4 vs. 48.3 %, P 
<  0.001,  respectively).  In  addition,  diabetic  patients  with 
thyroid dysfunction had higher values of BMI (31.76 ± 5.67 
vs. 30.65 ± 5.47 Kg/m2, P=0.03, respectively) and plasma 
HDL-cholesterol levels (51.70 ± 20.45 vs. 47.35 ± 18.91 mg/
dl, P = 0.01, respectively), and lower values of plasma LDL-
cholesterol levels (114.94 ± 41.48 vs. 128.05 ± 42.87 mg/
dl, P = 0.001, respectively) in comparison with the diabetic 
patients without thyroid dysfunction (Table 1). 
The univariate logistic analysis showed significant as-
sociations between the presence of thyroid dysfunction and 
gender [male vs. female, odds ratio (OR): 0.250, 95% Con-
fidence Intervals (95% CI): 0.168-0.390], BMI (OR: 1.036, 
95% CI: 1.004 -1.069), LDL-cholesterol levels (OR: 0.992, 
95% CI: 0.987 - 0.997) and HDL-cholesterol levels (OR: 
1.008, 95% CI: 1.000 - 1.017). No any significant relation-
ships were found between presence of thyroid dysfunction 
and age, duration of diabetes, blood pressure, microvascular 
and macrovascular complications (Table 2).   
Multivariate analysis demonstrated, after controlling for 
BMI, that presence of thyroid dysfunction was related only 
with gender (OR: 0.220, 95% CI: 0.141 - 0.352) and LDL-
cholesterol levels (OR: 0.990, 95% CI: 0.985 - 0.995) (Table 
2).
Discussion
  
The present study showed that in a sample of Greek diabetic 
patients the prevalence of thyroid dysfunction was 12.3%. 
The above results are in agreement with previous studies 
showing an association between T2D and thyroid dysfunc-
tion [1-5]. A study by Smithson et al. showed a prevalence of 
10.8% of thyroid dysfunction in diabetic patients registered 
in general practice [4]. Another study by Perros et al. in a 
randomly selected group of 1,310 diabetic adults estimated 
that the prevalence of thyroid dysfunction was found 13.4% 
[3]. A recent study reported that thyroid dysfunction was 
present in 16% of Saudi T2D patients [8]. Also, a study in 
Jordan showed that the overall prevalence of thyroid dys-
function was 12.5% in T2D patients [9].
In our study, we reported a higher prevalence of thyroid 
dysfunction among diabetic females. It is well established 
that hypothyroidism is more common in diabetic females. In 
a study by Perros et al. the prevalence of thyroid dysfunction 
was 10.9% in females and 6.9% in males [3]. The NHANES 
III study reported that the prevalence of subclinical hypothy-
roidism was 3.4% in males and 5.8% in females [10]. In ad-
dition, a study in 420 adult females with T2D randomly se-
lected from participants in the community-based Fremantle 
Diabetes Study showed that the prevalence of subclinical hy-
pothyroidism was 8.6% [11]. Finally, a recent study revealed 
that the prevalence of subclinical hypothyroidism was 5.2% 
in males and 8.4% in females with T2D [12]. 
In the present study we found that diabetic patients with 
thyroid disorders had better lipid profile, regarding LDL- and 
HDL-cholesterol  levels,  compared  with  diabetic  subjects 
without thyroid dysfunction. However, the existing literature 
data regarding the association between lipids and thyroid 
function are controversial. While dyslipidemia is a reported 
complication of overt hypothyroidism in nondiabetic [13-15] 
and diabetic [16] subjects, a recent meta-analysis [17] has 
showed that subclinical hypothyroidism does not seem to be 
associated with dyslipidemia. A study by Chubb et al. [11] 
did not find any significant relationship between subclini-
cal hypothyroidism and the presence of dyslipidemia. Also, 
in large studies of subclinical hypothyroidism and coronary 
heart disease [18-20], there was no association with raised 
serum cholesterol. An explanation of our findings was that 
all the participants were under thyroid hormone replacement 
therapy, which has been showed to improve serum lipids, in 
particular LDL-cholesterol levels [21, 22]. 
In conclusion, the present study showed that the preva-
lence of thyroid dysfunction among Greek diabetic patients 
Univariate analysis Multivariate analysis
Odds 
ratio
95% Confidence 
Intervals
P-value Odds 
ratio
95% Confidence 
Intervals
P-value
Gender 0.250 0.168 - 0.390 < 0.001 0.222 0.141 - 0.352 < 0.001
BMI 1.036 1.004 - 1.069 0.03 - - -
LDL- cholesterol 0.992 0.987 - 0.997 0.001 0.990 0.985 - 0.995 < 0.001
Table 2.  Univariate and Multivariate Logistic Analysis: The Association Between Various Parameters With Thyroid 
Dysfunction in T2D Patients
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attending an outpatient clinic was 12.3%. Diabetic women 
were more frequently affected than men. In addition, pres-
ence of thyroid dysfunction was associated with lower levels 
of LDL-cholesterol. However, as data were collected from a 
referral tertiary center of diabetes, they can not be extrapo-
lated to the total population. Therefore, larger epidemiologi-
cal studies are needed to estimate the prevalence of thyroid 
dysfunction in Greek T2D patients.
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